A low starting number can make two menopause services look directly comparable when they sell different pieces of care. Alloy's published product prices and Evernow's care fees are a good example: one medicine charge is not equivalent to one month of clinician access.
We checked the official treatment pages on September 21, 2026. This comparison concerns service structure, medication categories and published charges. It does not measure symptom improvement or rank the clinicians, and it cannot determine which prescription would be appropriate for you.
In this entry
Identify the medicine being compared
Write down the proposed ingredient, route and purpose before comparing a plan. A low-dose vaginal treatment for local symptoms is different from systemic estrogen used for symptoms such as hot flashes. A product photo or the word estrogen does not settle that distinction.
Our estradiol medicine guide explains why the route matters. Ask a clinician about the complete regimen, including any needed protection of the uterine lining. This keeps a comparison from silently leaving out another prescribed medicine.
Alloy's entries are product prices
Alloy lists an estradiol pill starting at $39.99 per month, a $100 patch and $69.99 gel or spray options. Progesterone has a separate starting price of $23. These figures are useful catalog facts; they are not a guarantee that every treatment plan can be bought for the lowest amount displayed.
Confirm the exact order, the number of months charged upfront and any consultation cost. Ask whether prescriptions are bundled and what happens when the regimen changes. Do not add unrelated medication entries together simply to create a hypothetical standard package.
Evernow's entries include different care routes
Evernow describes video visits and membership-based care. Its uninsured video price is $150, while membership starts at $35 per month. Medication is additional, with local pharmacy pickup and home delivery described as options.
Find out which route you need and whether any other fee applies to that selection. Then obtain the pharmacy price. A comparison of $35 membership with $100 of patches omits a different component on each side, so it does not identify the cheaper overall service.
Follow the insurance benefit through the whole plan
Evernow lists participating commercial plans for video appointments and describes possible medication coverage at a local pharmacy. Verify your own plan, deductible and product. Do not infer that insurance pays a separate membership charge from a statement about covered appointments.
For an Alloy order, ask how the quoted payment and medication arrangement work before assuming a catalog figure is an insurance copay. The cost checklist separates visits, recurring access, medicines and other expenses. The pharmacy-choice list adds services if keeping a specific pharmacy matters to you.
Approval belongs to the product
Evernow's FAQ includes compounded bioidentical formulations among its treatment options. Alloy's broader catalog includes compounded products as well as its approved hormone offerings. Neither catalog should be described as uniformly FDA-approved.
Ask which exact product is proposed and why. The compounded-medication guide explains the lack of FDA premarket review for those preparations. A provider's reputation, a personalization claim or another product's evidence does not establish the safety or effectiveness of a particular compound.
The decision still needs a written quote
Alloy may fit someone whose agreed treatment and ordering preferences match its product model. Evernow may fit someone choosing between a video conversation, ongoing messaging and pharmacy arrangements. Those are reasons to investigate the service, not guarantees of medical suitability.
Compare the same time period using the same intended medicines and expected contact. If the prescription being discussed is a patch, the patch-service shortlist adds practical refill and instruction questions. Keep treatment changes with the clinician rather than making them to match a cheaper advertised package.
CHECK THE ORIGINAL
The source record
Provider pages document their own offers. Medical and regulatory sources provide treatment context. This is not a record of personal patient testing. Latest source check: September 21, 2026.